BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 24155666)

  • 1. The many faces of C/EBPδ and their relevance for inflammation and cancer.
    Balamurugan K; Sterneck E
    Int J Biol Sci; 2013; 9(9):917-33. PubMed ID: 24155666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dual role of C/EBPδ in cancer.
    Hartl L; Duitman J; Bijlsma MF; Spek CA
    Crit Rev Oncol Hematol; 2023 May; 185():103983. PubMed ID: 37024021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs.
    Spek CA; Aberson HL; Butler JM; de Vos AF; Duitman J
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological roles of CCAAT/Enhancer-binding protein delta during inflammation.
    Ko CY; Chang WC; Wang JM
    J Biomed Sci; 2015 Jan; 22(1):6. PubMed ID: 25591788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation.
    Duitman J; Hartl L; Roelofs JJTH; Bijlsma MF; Spek CA
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
    Balamurugan K; Mendoza-Villanueva D; Sharan S; Summers GH; Dobrolecki LE; Lewis MT; Sterneck E
    Oncogene; 2019 May; 38(20):3765-3780. PubMed ID: 30262865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.
    Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
    Mendoza-Villanueva D; Balamurugan K; Ali HR; Kim SR; Sharan S; Johnson RC; Merchant AS; Caldas C; Landberg G; Sterneck E
    Oncogene; 2016 Dec; 35(48):6166-6176. PubMed ID: 27181204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
    Tang D; Sivko GS; DeWille JW
    Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4.
    Balamurugan K; Sharan S; Klarmann KD; Zhang Y; Coppola V; Summers GH; Roger T; Morrison DK; Keller JR; Sterneck E
    Nat Commun; 2013; 4():1662. PubMed ID: 23575666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of CCAAT/Enhancer Binding proteindelta (C/EBPdelta) target genes in G0 growth arrested mammary epithelial cells.
    Zhang Y; Liu T; Yan P; Huang T; Dewille J
    BMC Mol Biol; 2008 Oct; 9():83. PubMed ID: 18828910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide.
    Ramberg V; Tracy LM; Samuelsson M; Nilsson LN; Iverfeldt K
    J Neuroinflammation; 2011 Apr; 8():34. PubMed ID: 21492414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of mouse chondrocyte differentiation by CCAAT/enhancer-binding proteins.
    Okuma T; Hirata M; Yano F; Mori D; Kawaguchi H; Chung UI; Tanaka S; Saito T
    Biomed Res; 2015; 36(1):21-9. PubMed ID: 25749148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
    Sivko GS; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor C/EBP delta has anti-apoptotic and anti-inflammatory roles in pancreatic beta cells.
    Moore F; Santin I; Nogueira TC; Gurzov EN; Marselli L; Marchetti P; Eizirik DL
    PLoS One; 2012; 7(2):e31062. PubMed ID: 22347430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
    Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
    Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transducer and activator of transcription 3 activates CCAAT enhancer-binding protein delta gene transcription in G0 growth-arrested mouse mammary epithelial cells and in involuting mouse mammary gland.
    Hutt JA; O'Rourke JP; DeWille J
    J Biol Chem; 2000 Sep; 275(37):29123-31. PubMed ID: 10867011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pref-1 in brown adipose tissue: specific involvement in brown adipocyte differentiation and regulatory role of C/EBPδ.
    Armengol J; Villena JA; Hondares E; Carmona MC; Sul HS; Iglesias R; Giralt M; Villarroya F
    Biochem J; 2012 May; 443(3):799-810. PubMed ID: 22324440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.
    Balamurugan K; Wang JM; Tsai HH; Sharan S; Anver M; Leighty R; Sterneck E
    EMBO J; 2010 Dec; 29(24):4106-17. PubMed ID: 21076392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
    Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
    J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.